Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis
- 1 February 2006
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 51 (2), 181-191
- https://doi.org/10.1016/j.lungcan.2005.10.003
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Phospho-Akt Overexpression in Non–Small Cell Lung Cancer Confers Significant Stage-Independent Survival DisadvantageClinical Cancer Research, 2004
- RRM1 and PTEN As Prognostic Parameters for Overall and Disease-Free Survival in Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2004
- Prognostic Significance of Activated Akt Expression in Pancreatic Ductal AdenocarcinomaClinical Cancer Research, 2004
- Variable apoptotic response of NSCLC cells to inhibition of the MEK/ERK pathway by small molecules or dominant negative mutantsCell Death & Differentiation, 2002
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- Loss of Expression of the PTEN Gene Protein Product Is Associated with Poor Outcome in Breast CancerLaboratory Investigation, 2001
- Activation of Akt (Protein Kinase B) in Mammary Epithelium Provides a Critical Cell Survival Signal Required for Tumor ProgressionMolecular and Cellular Biology, 2001
- The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cellsOncogene, 1999
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- Inhibition of Cell Migration, Spreading, and Focal Adhesions by Tumor Suppressor PTENScience, 1998